These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22309662)

  • 21. Personalized neoantigen vaccines: a glimmer of hope for glioblastoma.
    Londhe VY; Date V
    Expert Rev Vaccines; 2020 May; 19(5):407-417. PubMed ID: 32238056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Immunotherapies for Glioblastoma Multiforme.
    Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
    Front Immunol; 2020; 11():603911. PubMed ID: 33767690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma.
    Johanns TM; Garfinkle EAR; Miller KE; Livingstone AJ; Roberts KF; Rao Venkata LP; Dowling JL; Chicoine MR; Dacey RG; Zipfel GJ; Kim AH; Mardis ER; Dunn GP
    Clin Cancer Res; 2024 Jul; 30(13):2729-2742. PubMed ID: 38639919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DCVax-Brain and DC vaccines in the treatment of GBM.
    Wheeler CJ; Black KL
    Expert Opin Investig Drugs; 2009 Apr; 18(4):509-19. PubMed ID: 19335279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.
    Miao H; Choi BD; Suryadevara CM; Sanchez-Perez L; Yang S; De Leon G; Sayour EJ; McLendon R; Herndon JE; Healy P; Archer GE; Bigner DD; Johnson LA; Sampson JH
    PLoS One; 2014; 9(4):e94281. PubMed ID: 24722266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standards of care and novel approaches in the management of glioblastoma multiforme.
    Hottinger AF; Stupp R; Homicsko K
    Chin J Cancer; 2014 Jan; 33(1):32-9. PubMed ID: 24384238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Vaccines for Malignant Gliomas.
    Srinivasan VM; Ferguson SD; Lee S; Weathers SP; Kerrigan BCP; Heimberger AB
    Neurotherapeutics; 2017 Apr; 14(2):345-357. PubMed ID: 28389997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial.
    Ji N; Zhang Y; Liu Y; Xie J; Wang Y; Hao S; Gao Z
    JCI Insight; 2018 May; 3(10):. PubMed ID: 29769450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma.
    Gedeon PC; Choi BD; Hodges TR; Mitchell DA; Bigner DD; Sampson JH
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):375-86. PubMed ID: 23927666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
    Heimberger AB; Sun W; Hussain SF; Dey M; Crutcher L; Aldape K; Gilbert M; Hassenbusch SJ; Sawaya R; Schmittling B; Archer GE; Mitchell DA; Bigner DD; Sampson JH
    Neuro Oncol; 2008 Feb; 10(1):98-103. PubMed ID: 18079360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DCVax®-L--developed by Northwest Biotherapeutics.
    Polyzoidis S; Ashkan K
    Hum Vaccin Immunother; 2014; 10(11):3139-45. PubMed ID: 25483653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promising vaccines for treating glioblastoma.
    Swartz AM; Shen SH; Salgado MA; Congdon KL; Sanchez-Perez L
    Expert Opin Biol Ther; 2018 Nov; 18(11):1159-1170. PubMed ID: 30281978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide vaccines for the treatment of glioblastoma.
    Swartz AM; Batich KA; Fecci PE; Sampson JH
    J Neurooncol; 2015 Jul; 123(3):433-40. PubMed ID: 25491947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in Immunotherapy for Glioblastoma Multiforme.
    Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
    J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.
    Latzer P; Zelba H; Battke F; Reinhardt A; Shao B; Bartsch O; Rabsteyn A; Harter J; Schulze M; Okech T; Golf A; Kyzirakos-Feger C; Kayser S; Pieper N; Feldhahn M; Wünsche J; Seitz C; Hadaschik D; Garbe C; Hauser TK; la Fougère C; Biskup D; Brooke D; Parker D; Martens UM; Illerhaus G; Blumenthal DT; Merrell R; Lorenzo LS; Hidvégi M; de Robles P; Kebir S; Li WW; Li VW; Williams M; Miller AM; Kesari S; Castro M; Desjardins A; Ashley DM; Friedman HS; Wen PY; Neil EC; Iwamoto FM; Sipos B; Geletneky K; Zender L; Glas M; Reardon DA; Biskup S
    Nat Commun; 2024 Aug; 15(1):6870. PubMed ID: 39127809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
    Reardon DA; Desjardins A; Vredenburgh JJ; O'Rourke DM; Tran DD; Fink KL; Nabors LB; Li G; Bota DA; Lukas RV; Ashby LS; Duic JP; Mrugala MM; Cruickshank S; Vitale L; He Y; Green JA; Yellin MJ; Turner CD; Keler T; Davis TA; Sampson JH;
    Clin Cancer Res; 2020 Apr; 26(7):1586-1594. PubMed ID: 32034072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
    Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
    Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current vaccine trials in glioblastoma: a review.
    Xu LW; Chow KK; Lim M; Li G
    J Immunol Res; 2014; 2014():796856. PubMed ID: 24804271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of a peptide-based vaccine for glioblastoma.
    Kanaly CW; Ding D; Heimberger AB; Sampson JH
    Neurosurg Clin N Am; 2010 Jan; 21(1):95-109. PubMed ID: 19944970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.